BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 4787510)

  • 1. [Effects of treatment with neuraminidase on the immunogenicity of ATPC tumor cells].
    Iorio AM; Rivosecchi P; Santoni A; Fabiani L
    Boll Soc Ital Biol Sper; 1973 Mar; 49(9):462-6. PubMed ID: 4787510
    [No Abstract]   [Full Text] [Related]  

  • 2. Immunological stimulation with modified lymphoma cells in a minimally responsive tumor-host system.
    Prager MD; Baechtel FS; Ribble RJ; Ludden CM; Mehta JM
    Cancer Res; 1974 Dec; 34(12):3203-9. PubMed ID: 4429949
    [No Abstract]   [Full Text] [Related]  

  • 3. Differential effect of neuraminidase on the immunogenicity of viral associated and private antigens of mammary carcinomas.
    Simmons RL; Rios A
    J Immunol; 1973 Dec; 111(6):1820-5. PubMed ID: 4750868
    [No Abstract]   [Full Text] [Related]  

  • 4. [Transplantability and immunogenicity in mice of lymphoma Nk/Ly cells modified by concanavalin A and neuraminidase].
    Bratus' GG; Darchuk GF
    Eksp Onkol; 1989; 11(3):35-8. PubMed ID: 2752940
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Immunogenicity of L5178Y cells modified by different reagents].
    Gómez-Estrada H; López-de la Rosa LM; Becerril-Meza G; Arellano-Blanco J; Fernández-Quintero P
    Arch Invest Med (Mex); 1977; 8(2):113-22. PubMed ID: 410377
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effectiveness of neuraminidase in experimental immunotherapy of two murine pulmonary carcinomas.
    Alley CD; Snodgrass MJ
    Cancer Res; 1977 Jan; 37(1):95-101. PubMed ID: 830425
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative immunotherapeutic effect of concanavalin A and neuraminidase-treated cancer cells.
    Simmons RL; Rios A
    Transplant Proc; 1975 Jun; 7(2):247-51. PubMed ID: 1129845
    [No Abstract]   [Full Text] [Related]  

  • 8. Micro-necrotic foci in regression of a murine calvarium transplantable tumor. 2. Enzymatic modification of the transformed calvarium cell immunological characteristics.
    Hakim AA
    Neoplasma; 1980; 27(4):449-58. PubMed ID: 7453860
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunotherapy with neuraminidase-treated tumor cells after radiotherapy.
    Song CW; Levitt SH
    Radiat Res; 1975 Dec; 64(3):485-91. PubMed ID: 1197655
    [No Abstract]   [Full Text] [Related]  

  • 10. Basic proteins and synthetic polynucleotides as modifiers of immunogenicity of syngeneic tumor cells.
    Braun W; Plescia OJ; Raskova J; Webb D
    Isr J Med Sci; 1971 Jan; 7(1):72-82. PubMed ID: 4100526
    [No Abstract]   [Full Text] [Related]  

  • 11. Neuraminidase treated cells and their role in cancer immunotherapy.
    Simmons RL; Rios A
    Birth Defects Orig Artic Ser; 1973 Mar; 9(2):223-8. PubMed ID: 4611534
    [No Abstract]   [Full Text] [Related]  

  • 12. Possible immunological action of Vibrio cholerae neuraminidase (VCN) in tumor immunotherapy.
    Sedlacek HH; Johannsen R; Seiler FR
    Dev Biol Stand; 1977 Apr 13-15; 38():387-98. PubMed ID: 608528
    [No Abstract]   [Full Text] [Related]  

  • 13. Stimulatory effect of Vibrio cholerae neuraminidase on the antibody response to various antigens.
    Knop J; Sedlacek HH; Seiler FR
    Immunology; 1978 Feb; 34(2):181-7. PubMed ID: 342397
    [No Abstract]   [Full Text] [Related]  

  • 14. Active specific immunotherapy of minimal residual tumor: excision plus neuraminidase-treated tumor cells.
    Rios A; Simmons RL
    Int J Cancer; 1974 Jan; 13(1):71-81. PubMed ID: 4818273
    [No Abstract]   [Full Text] [Related]  

  • 15. In vitro evidence that Vibrio Cholerae neuraminidase increases antigenicity of sarcoma cells.
    Faraci RP; Ketcham AS
    Surg Forum; 1974; 25(0):99-101. PubMed ID: 4439267
    [No Abstract]   [Full Text] [Related]  

  • 16. Quantitative effects of nutritional protein and calorie deficiency upon immune responses to tumors in mice.
    Jose DG; Good RA
    Cancer Res; 1973 Apr; 33(4):807-12. PubMed ID: 4633154
    [No Abstract]   [Full Text] [Related]  

  • 17. Immunogenicity of leukemia L1210 cells after neuraminidase treatment.
    Bekesi JG; St Arneault G; Walter L; Holland JF
    J Natl Cancer Inst; 1972 Jul; 49(1):107-18. PubMed ID: 4338766
    [No Abstract]   [Full Text] [Related]  

  • 18. [The morphofunctional characteristics of lymphoma NK/LY cells treated with concanavalin A and Vibrio cholerae neuraminidase].
    Bratus' GG; Naumenko OI; Nastenko EP; Novichenko NL
    Tsitologiia; 1990; 32(1):67-73. PubMed ID: 2375060
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antibody response to ATPC+ascites tumour in mice rendered resistant by intravenous inoculation of liver cells.
    Pitzurra M; Marconi P
    Boll Ist Sieroter Milan; 1972; 51(5):393-404. PubMed ID: 4656954
    [No Abstract]   [Full Text] [Related]  

  • 20. [Action of Vibrio cholera neuraminidase on chemically induced carcinogenesis].
    Solov'ev VD; Maĭskiĭ IN; Aĭrapet'ian GP; Kobrinskiĭ GD; Gudkova RB
    Vestn Akad Med Nauk SSSR; 1974; (8):63-6. PubMed ID: 4471645
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.